Group One Trading
MRNA icon

Group One Trading’s Moderna MRNA Stock Holding History

Group One Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
203,915
+156,014
+326% +$8.07M 0.02% 742
2026
Q1 		$2.43M Sell
47,901
-142,054
-75% -$6.63M ﹤0.01% 1902
2025
Q4 		$5.6M Sell
189,955
-115,862
-38% -$3.15M 0.01% 1387
2025
Q3 		$7.9M Sell
305,817
-67,871
-18% -$1.89M 0.01% 1093
2025
Q2 		$10.3M Sell
373,688
-70,750
-16% -$1.86M 0.02% 798
2025
Q1 		$12.6M Buy
444,438
+192,534
+76% +$6.83M 0.04% 525
2024
Q4 		$10.5M Buy
251,904
+74,831
+42% +$3.58M 0.02% 670
2024
Q3 		$11.8M Buy
177,073
+70,323
+66% +$6.46M 0.03% 521
2024
Q2 		$12.7M Buy
106,750
+73,667
+223% +$9.32M 0.05% 334
2024
Q1 		$3.53M Sell
33,083
-21,750
-40% -$2.19M 0.01% 1072
2023
Q4 		$5.45M Sell
54,833
-33,330
-38% -$2.8M 0.01% 1064
2023
Q3 		$9.11M Sell
88,163
-19,598
-18% -$2.19M 0.03% 574
2023
Q2 		$13.1M Buy
107,761
+46,469
+76% +$6.2M 0.04% 390
2023
Q1 		$9.41M Sell
61,292
-146,604
-71% -$24.2M 0.03% 495
2022
Q4 		$37.3M Buy
207,896
+11,806
+6% +$1.93M 0.09% 211
2022
Q3 		$23.2M Buy
196,090
+52,331
+36% +$7.94M 0.05% 333
2022
Q2 		$20.5M Buy
143,759
+78,361
+120% +$11.2M 0.03% 473
2022
Q1 		$11.3M Buy
+65,398
New +$11M 0.01% 921
2021
Q2 		– Sell
-262,902
Closed -$47M – 8404
2021
Q1 		$34.4M Buy
262,902
+173,091
+193% +$25.1M 0.05% 331
2020
Q4 		$9.38M Buy
89,811
+25,270
+39% +$2.56M 0.02% 837
2020
Q3 		$4.57M Sell
64,541
-226,119
-78% -$15.8M 0.01% 983
2020
Q2 		$18.7M Buy
290,660
+125,369
+76% +$6.87M 0.09% 246
2020
Q1 		$4.95M Buy
+165,291
New +$3.8M 0.04% 541
2019
Q4 		– Sell
-85,799
Closed -$1.52M – 5427
2019
Q3 		$1.37M Buy
85,799
+52,210
+155% +$771K 0.01% 1497
2019
Q2 		$492K Buy
+33,589
New +$721K ﹤0.01% 2149
2019
Q1 		– Sell
-23
Closed -$427 – 5151
2018
Q4 		$0 Buy
+23
New +$378 ﹤0.01% 5205

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Group One Trading's MRNA Position: Q2 2026 in Review

Group One Trading increased its Moderna (MRNA) stake by 326% in Q2 2026, buying an estimated $8.07M and bringing the position to 203,915 shares worth $14.3M. The position accounts for 0.02% of the portfolio, ranked #742.

Group One Trading first reported a position in MRNA in Q4 2018 and has held it in 26 quarters since. The position peaked at $37.3M in Q4 2022. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Group One Trading held 203,915 shares of Moderna worth $14.3M as of Q2 2026.
  • Group One Trading bought 156,014 Moderna shares in Q2 2026, an estimated $8.07M.
  • Moderna made up 0.02% of Group One Trading's portfolio in Q2 2026, its #742 holding.
  • Group One Trading first reported a position in Moderna in Q4 2018 and has held it in 26 quarters since.
  • Group One Trading's Moderna position peaked at $37.3M in Q4 2022.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.